Abstract
The myelodysplastic syndrome (MDS) or preleukaemia is a haematological disorder characterized by low blood counts, bone marrow cells of abnormal appearance and progression to acute leukaemia in as many as 30% of patients1. The distinctive pre-leukaemic and leukaemic phases of this disease make it an attractive model for neoplastic progression in human tumours. We reasoned that, because dominantly transforming genes (such as mutant alleles of ras proto-oncogenes) are found so frequently in acute leukaemia2, the search for these genetic lesions during the clinical course of patients with MDS might give us insight into the function of oncogenes in leukaemogenesis. We report here that bone marrow cells from two of four patients with preleukaemia, and from one patient who progressed to acute leukaemia from MDS, contained a transforming allele of the Ki-ras proto-oncogene. In one preleukaemic patient, a novel mutation in codon 13 of this ras gene was detected in bone marrow cells harvested 1.5 years before the acute leukaemia developed. Our findings provide evidence that ras mutations may be involved in the early stages of human leukaemia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
1. Greenberg, P. L. & Mara, B. Am. J. Med. 66, 951-958 (1979). 2. Bos, J. L. et al Blood 69, 1237-1241 (1987). 3. Bitter, M. A. et al. Blood 66, 1362-1370 (1985). 4. Fasano, O. et al. Molec. cell. Biol. 4, 1695-1705 (1984). 5. Blair, D. G. et al Science 218, 1122-1124 (1982). 6. Barbacid, M. A. Rev. Biochem. 56, 779-828 (1987). 7. McGrath, J. P. et al. Nature 304, 501-506 (1983). 8. Chen, E. Y. & Seeburg, P. H. DNA 4, 165-170 (1985). 9. Davis, L. G., Dibner, M. D. & Battey, J. F. Basic Methods in Molecular Biology 44-46 (Elsevier, New York, 1986). 10. Bos, J. L. et al. Nature 315, 726-730 (1985). 11. Saiki, R. K. et al. Science 230, 1350-1352 (1985). 12. Zarbl, H., Saraswati, S., Arthur, A. V., Martin-Zanca, D. & Barbacid, M. Nature 315, 382-386 (1985). 13. Brown, K. et al. Cell 46, 447-456 (1986). 14. Quaife, C. J., Pinkert, C. A., Onnitz, D. M., Palmiter, R. D. & Brinster, R. L. Cell 48, 1023-1034 (1987). 15. Bos, J. L. et al. Nature 327, 293-297 (1987). 16. Hirai, H. et al. Nature 327, 430-432 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, E., Hjelle, B., Morgan, R. et al. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia. Nature 330, 186–188 (1987). https://doi.org/10.1038/330186a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/330186a0
This article is cited by
-
Clinical impact of genetic and molecular markers in myelodysplastic syndromes (MDS)
memo - Magazine of European Medical Oncology (2009)
-
Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study
Annals of Hematology (2008)
-
FAB classification of myelodysplastic syndromes: merits and controversies
Annals of Hematology (1995)
-
Mutant c-Ki-ras p21 protein in chemical carcinogenesis in humans exposed to vinyl chloride
Cancer Causes & Control (1994)
-
Oncogenes: Present status
The Indian Journal of Pediatrics (1993)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.